Acrivon Therapeutics Inc (ACRV)

Jul 24, 2025

How high can Acrivon Therapeutics Inc. stock price go in 2025Free Group Entry - Newser

Jul 24, 2025

Jul 23, 2025

Acrivon Therapeutics Inc. Stock Analysis and ForecastAccelerated earnings growth - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

What analysts say about Acrivon Therapeutics Inc. stockRapid wealth creation - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

Is Acrivon Therapeutics Inc. a good long term investmentHigh-octane investment gains - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Here's Why We're Watching Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Situation - Yahoo Finance

Jul 22, 2025

Jul 22, 2025

What drives Acrivon Therapeutics Inc. stock priceConsistently superior profits - PrintWeekIndia

Jul 22, 2025

Jul 18, 2025

Is Acrivon Therapeutics Inc. stock a good hedge against inflationSolid Return Trade Selections - beatles.ru

Jul 18, 2025

Jul 17, 2025

Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives Average Rating of “Buy” from Analysts - Defense World

Jul 17, 2025

Jul 17, 2025

Analysts Set Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Target Price at $17.71 - Defense World

Jul 17, 2025

Jul 16, 2025

What makes Acrivon Therapeutics Inc. stock price move sharplyFree Stock Market Real-Time Monitoring - Newser

Jul 16, 2025

Jul 15, 2025

Cantor Fitzgerald sets Acrivon stock to Overweight on AP3 platform - MSN

Jul 15, 2025

Jul 15, 2025

How Acrivon Therapeutics Inc. stock performs during market volatilityAlpha Stock Ideas - Newser

Jul 15, 2025

Jul 15, 2025

Endometrial Cancer Clinical Trial Pipeline Insights: 50+ Companies Shaping Future Treatment Paradigms | DelveInsight - GlobeNewswire Inc.

Jul 15, 2025

Jul 15, 2025

Why Acrivon Therapeutics Inc. stock attracts strong analyst attentionExpert Backed Predictions - Newser

Jul 15, 2025

Jul 12, 2025

(ACRV) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 12, 2025

Jul 11, 2025

Acrivon Therapeutics (NASDAQ:ACRV) Trading 0.7% Higher – Still a Buy? - Defense World

Jul 11, 2025

Jun 22, 2025

Acrivon Therapeutics, Inc.(NasdaqGM: ACRV) dropped from S&P Global BMI Index - MarketScreener

Jun 22, 2025

Jun 21, 2025

Learn to Evaluate (ACRV) using the Charts - news.stocktradersdaily.com

Jun 21, 2025

Jun 13, 2025

Acrivon Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 13, 2025

Jun 12, 2025

Analysts Offer Predictions for ACRV FY2026 Earnings - Defense World

Jun 12, 2025

Jun 10, 2025

Long Term Trading Analysis for (ACRV) - news.stocktradersdaily.com

Jun 10, 2025

Jun 07, 2025

Nuveen Asset Management LLC Sells 12,377 Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV) - Defense World

Jun 07, 2025

May 31, 2025

Northern Trust Corp Has $706,000 Stock Position in Acrivon Therapeutics, Inc. (NASDAQ:ACRV) - Defense World

May 31, 2025